Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??
Panayotis KaloyannidisFatema AbdullaEnas MutaharHaidar Al HashimSalman Al HarbiAnalie EstanislaoHani Al HashmiPublished in: Journal of blood medicine (2022)
The proposed scoring system could be reliably used at diagnosis and at interim disease evaluation in aiming for personalized treatment for young NDMM patients.